Naoki Hosen

6.1k total citations
111 papers, 2.9k citations indexed

About

Naoki Hosen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Naoki Hosen has authored 111 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 41 papers in Oncology and 35 papers in Immunology. Recurrent topics in Naoki Hosen's work include Renal and related cancers (44 papers), CAR-T cell therapy research (29 papers) and Immunotherapy and Immune Responses (18 papers). Naoki Hosen is often cited by papers focused on Renal and related cancers (44 papers), CAR-T cell therapy research (29 papers) and Immunotherapy and Immune Responses (18 papers). Naoki Hosen collaborates with scholars based in Japan, United States and Australia. Naoki Hosen's co-authors include Haruo Sugiyama, Yusuke Oji, Yoshitaka Oka, Akihiro Tsuboi, Irving L. Weissman, Sumiyuki Nishida, Naoya Tatsumi, Manabu Kawakami, Hiroko Nakajima and Alan M. Krensky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.

In The Last Decade

Naoki Hosen

100 papers receiving 2.8k citations

Peers

Countries citing papers authored by Naoki Hosen

Since Specialization

Citations

This map shows the geographic impact of Naoki Hosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Hosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Hosen more than expected).

Fields of papers citing papers by Naoki Hosen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Hosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Hosen. The network helps show where Naoki Hosen may publish in the future.

Co-authorship network of co-authors of Naoki Hosen

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Hosen. A scholar is included among the top collaborators of Naoki Hosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Hosen. Naoki Hosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM) 2025 ·International Journal of Hematology ·Shinsuke Iida, Shigeki Ito, Kazutaka Sunami, Hiroyuki Takamatsu, Nobuhiro Tsukada, Naoki Hosen, Hirokazu Miki	0
2	A nonactivating ITGB3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathway 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Daisuke Motooka, Daisuke Okuzaki, (unknown), Yoshiaki Tomiyama, Naoki Hosen, Hirokazu Kashiwagi	0
3	A newly identified gene Ahed plays essential roles in murine haematopoiesis 2024 ·Nature Communications ·(unknown), Takafumi Yokota, Masahiro Tokunaga, Mikiro Takaishi, Tomomasa Yokomizo, Takao Sudo, (unknown), Yoshiaki Yasumizu, Daisuke Okuzaki, Chikara Kokubu, Sachiyo Tanaka, Katsuyoshi Takaoka, (unknown), (unknown), Hitomi Watanabe, Gen Kondoh, Kyoji Horie, Naoki Hosen, Shigetoshi Sano, Junji Takeda	1
4	Identification of cancer-specific cell surface targets for CAR-T cell therapy 2024 ·Inflammation and Regeneration ·Naoki Hosen	7
5	Special AT-Rich Sequence-Binding Protein 1 Supports Survival and Maturation of Naive B Cells Stimulated by B Cell Receptors 2022 ·The Journal of Immunology ·Takayuki Ozawa, Kentaro Fujii, Takao Sudo, Yukiko Doi, (unknown), (unknown), (unknown), Yoshihiro Baba, Naoki Hosen, Takafumi Yokota	4
6	Spatiotemporal reprogramming of differentiated cells underlies regeneration and neoplasia in the intestinal epithelium 2022 ·Nature Communications ·(unknown), Yasutaka Okita, Akinobu Matsumoto, (unknown), (unknown), (unknown), (unknown), Shoichiro Takeishi, Hirokazu Nakatsumi, Naoki Hosen, Sylvie Robine, Makoto M. Taketo, Toshiro Sato, Keiichi I. Nakayama	30
7	T Cell-Intrinsic Vitamin A Metabolism and Its Signaling Are Targets for Memory T Cell-Based Cancer Immunotherapy 2022 ·Frontiers in Immunology ·Fumihiro Fujiki, Soyoko Morimoto, (unknown), (unknown), (unknown), (unknown), (unknown), Ayako Isotani, Masahito Ikawa, Sumiyuki Nishida, Hiroko Nakajima, Akihiro Tsuboi, Yoshitaka Oka, Jun Nakata, Naoki Hosen, Atsushi Kumanogoh, Yusuke Oji, Haruo Sugiyama	8
8	Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides 2020 ·Cancer Immunology Immunotherapy ·Fumihiro Fujiki, Akihiro Tsuboi, Soyoko Morimoto, Naoya Hashimoto, (unknown), Hiroko Nakajima, Jun Nakata, Sumiyuki Nishida, Kana Hasegawa, Naoki Hosen, Yoshitaka Oka, Yusuke Oji, Shinji Sogo, Haruo Sugiyama	7
9	Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML 2020 ·Oncogene ·(unknown), Michiko Ichii, Kenji Oritani, Hirohiko Shibayama, Akira Tanimura, Hideaki Saito, Takafumi Yokota, Daisuke Motooka, Daisuke Okuzaki, Yuichi Kitai, Ryuta Muromoto, Jun‐ichi Kashiwakura, Tadashi Matsuda, Naoki Hosen, Yuzuru Kanakura	13
10	Chimeric antigen receptor T-cell therapy for multiple myeloma 2020 ·International Journal of Hematology ·Naoki Hosen	6
11	Chimeric antigen receptor T cell therapy for multiple myeloma 2019 ·Inflammation and Regeneration ·Kana Hasegawa, Naoki Hosen	7
12	A phase I clinical study of a cocktail vaccine of Wilms’ tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma 2018 ·Cancer Immunology Immunotherapy ·Akihiro Tsuboi, Naoya Hashimoto, Fumihiro Fujiki, Soyoko Morimoto, Naoki Kagawa, Hiroko Nakajima, Naoki Hosen, Sumiyuki Nishida, Jun Nakata, Satoshi Morita, Junichi Sakamoto, Yusuke Oji, Yoshitaka Oka, Haruo Sugiyama	43
13	Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response 2015 ·Cancer Immunology Immunotherapy ·Naoya Hashimoto, Akihiro Tsuboi, Naoki Kagawa, Yasuyoshi Chiba, Shuichi Izumoto, Manabu Kinoshita, Noriyuki Kijima, Yoshitaka Oka, Soyoko Morimoto, Hiroko Nakajima, Satoshi Morita, Junichi Sakamoto, Sumiyuki Nishida, Naoki Hosen, Yusuke Oji, Norio Arita, Toshiki Yoshimine, Haruo Sugiyama	34
14	Vaccination strategies to improve outcome of hematopoietic stem cell transplant in leukemia patients: early evidence and future prospects 2014 ·Expert Review of Hematology ·Naoki Hosen, Tetsuo Maeda, Yoshiko Hashii, Akihiro Tsuboi, Sumiyuki Nishida, Jun Nakata, Yoshiki Nakae, S Takashima, Yusuke Oji, Yoshitaka Oka, Atsushi Kumanogoh, Haruo Sugiyama	4
15	WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide 2009 ·Anti-Cancer Agents in Medicinal Chemistry ·Yoshitaka Oka, Akihiro Tsuboi, Fumihiro Fujiki, Zheyu Li, Hiroko Nakajima, Naoki Hosen, Toshiaki Shirakata, Sumiyuki Nishida, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama	17
16	Biased usage of BV gene families of T‐cell receptors of WT1 (Wilms’ tumor gene)‐specific CD8⁺ T cells in patients with myeloid malignancies 2009 ·Cancer Science ·(unknown), Manabu Kawakami, Yoshitaka Oka, Akihiro Tsuboi, Takamasa Katagiri, (unknown), Sumiyuki Nishida, Toshiaki Shirakata, Naoki Hosen, Fumihiro Fujiki, (unknown), Hiroko Nakajima, Yusuke Oji, Yoshinobu Kanda, Ichiro Kawase, Haruo Sugiyama	14
17	Transcriptional Profiling of Antigen-Dependent Murine B Cell Differentiation and Memory Formation 2007 ·The Journal of Immunology ·Deepta Bhattacharya, (unknown), Christopher B. Franco, Naoki Hosen, Christopher L. Pin, William C. Sha, Irving L. Weissman	134
18	Wilms’ tumor gene WT1 17AA(–)/KTS(–) isoform induces morphological changes and promotes cell migration and invasion in vitro 2006 ·Cancer Science ·Tanyarat Jomgeow, Yusuke Oji, (unknown), Yoko Ikeda, Ken Ito, (unknown), Tsutomu Nakazawa, Naoya Tatsumi, (unknown), S Takashima, Toshiaki Shirakata, Sumiyuki Nishida, Naoki Hosen, Manabu Kawakami, Akihiro Tsuboi, Yoshitaka Oka, Kazuyuki Itoh, Haruo Sugiyama	57
19	Wilms tumor gene peptide-based immunotherapy for patients with overt Leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis 2003 ·International Journal of Hematology ·Yoshitaka Oka, Akihiro Tsuboi, Masaki Murakami, Manabu Hirai, Nobuhiko Tominaga, Hiroko Nakajima, Olga A. Elisseeva, Tomoki Masuda, Akiko Nakano, Manabu Kawakami, Yusuke Oji, Kazuhiro Ikegame, Naoki Hosen, Keiko Udaka, Masaki Yasukawa, Hiroyasu Ogawa, Ichiro Kawase, Haruo Sugiyama	90
20	[New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation]. 1999 ·PubMed ·Naoki Hosen, (unknown), Takahiro Karasuno, (unknown), (unknown), Tetsuya Yagi, Kazuo Hatanaka, (unknown), A Hiraoka, (unknown), Toru Masaoka	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact